Importantly, the BCL-XL-selective inhibitor A-1155463 is not efficacious as a single agent or in combination with MCL-1 inhibitors in BCL2High NHL cell lines in vitro. Here, BCL2L1 is linked to non-Hodgkin lymphoma.